24th February 2025

A 79-year-old gentleman with pancreatic cancer is being seen in the oncology clinic for his mid-treatment review

A 79-year-old gentleman with pancreatic cancer is being seen in the oncology clinic for his mid-treatment review. He has had four cycles of gemcitabine-abraxane chemotherapy for metastatic pancreatic cancer. His treatment to date has been complicated by neutropenia with neutrophil count of 0.3 x 10⁹/L with his first cycle of chemotherapy, for which he was treated with antibiotics and G-CSF. Since then, he has tolerated treatment well. His other comorbidities include hypertension, diabetes mellitus and osteoarthritis.

Which of the following is not a risk factor for developing neutropenic sepsis again in future?

Select the SINGLE most appropriate option from the list below. Select ONE option only.